LENZ Therapeutics (LENZ) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2026)
LENZ Therapeutics (LENZ) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | LENZ Therapeutics | 177.61 Mn | -80.77 Mn | 825,000.00 | 18.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.36% |
| Dec 31, 2025 | 82.64% |
| Sep 30, 2025 | 238.17% |
| Jun 30, 2025 | 612.80% |
| Mar 31, 2025 | 1,789.80% |
| Dec 31, 2024 | 1,105.56% |
| Sep 30, 2024 | -97.03% |
| Jun 30, 2024 | -99.09% |
| Mar 31, 2024 | -99.85% |
| Dec 31, 2023 | -99.76% |
| Sep 30, 2023 | -5.55% |
| Jun 30, 2023 | 71.63% |
| Mar 31, 2023 | 252.78% |
| Dec 31, 2022 | 247.78% |
| Sep 30, 2022 | 127.46% |
| Jun 30, 2022 | 346.73% |
| Dec 31, 2021 | 345.38% |